Keywords
Last Name
Institution

Mark P Rubinstein

Title
InstitutionMedical University of South Carolina
DepartmentSurgery
AddressP.O. Box MSC 613
512
86 Jonathan Lucas St.
Phone843-792-1451
Fax843-792-3315
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Chakraborty P, Chatterjee S, Kesarwani P, Thyagarajan K, Iamsawat S, Dalheim A, Nguyen H, Selvam SP, Nasarre P, Scurti G, Hardiman G, Maulik N, Ball L, Gangaraju V, Rubinstein MP, Klauber-DeMore N, Hill EG, Ogretmen B, Yu XZ, Nishimura MI, Mehrotra S. Thioredoxin-1 improves the immunometabolic phenotype of antitumor T cells. J Biol Chem. 2019 Jun 07; 294(23):9198-9212. PMID: 30971427.
      View in: PubMed
    2. Dwyer CJ, Knochelmann HM, Smith AS, Wyatt MM, Rangel Rivera GO, Arhontoulis DC, Bartee E, Li Z, Rubinstein MP, Paulos CM. Fueling Cancer Immunotherapy With Common Gamma Chain Cytokines. Front Immunol. 2019; 10:263. PMID: 30842774.
      View in: PubMed
    3. Li Z, Song W, Rubinstein M, Liu D. Recent updates in cancer immunotherapy: a comprehensive review and perspective of the 2018 China Cancer Immunotherapy Workshop in Beijing. J Hematol Oncol. 2018 Dec 21; 11(1):142. PMID: 30577797.
      View in: PubMed
    4. Johnson CB, May BR, Riesenberg BP, Suriano S, Mehrotra S, Garrett-Mayer E, Salem ML, Jeng EK, Wong HC, Paulos CM, Wrangle JM, Cole DJ, Rubinstein MP. Enhanced Lymphodepletion Is Insufficient to Replace Exogenous IL2 or IL15 Therapy in Augmenting the Efficacy of Adoptively Transferred Effector CD8+ T Cells. Cancer Res. 2018 06 01; 78(11):3067-3074. PMID: 29636345.
      View in: PubMed
    5. Wrangle JM, Velcheti V, Patel MR, Garrett-Mayer E, Hill EG, Ravenel JG, Miller JS, Farhad M, Anderton K, Lindsey K, Taffaro-Neskey M, Sherman C, Suriano S, Swiderska-Syn M, Sion A, Harris J, Edwards AR, Rytlewski JA, Sanders CM, Yusko EC, Robinson MD, Krieg C, Redmond WL, Egan JO, Rhode PR, Jeng EK, Rock AD, Wong HC, Rubinstein MP. ALT-803, an IL-15 superagonist, in combination with nivolumab in patients with metastatic non-small cell lung cancer: a non-randomised, open-label, phase 1b trial. Lancet Oncol. 2018 05; 19(5):694-704. PMID: 29628312.
      View in: PubMed
    6. Wrangle JM, Patterson A, Johnson CB, Neitzke DJ, Mehrotra S, Denlinger CE, Paulos CM, Li Z, Cole DJ, Rubinstein MP. IL-2 and Beyond in Cancer Immunotherapy. J Interferon Cytokine Res. 2018 Feb; 38(2):45-68. PMID: 29443657.
      View in: PubMed
    7. Riley JM, Cross AW, Paulos CM, Rubinstein MP, Wrangle J, Camp ER. The clinical implications of immunogenomics in colorectal cancer: A path for precision medicine. Cancer. 2018 Apr 15; 124(8):1650-1659. PMID: 29315503.
      View in: PubMed
    8. Liu D, Li G, Avella DM, Kimchi ET, Kaifi JT, Rubinstein MP, Camp ER, Rockey DC, Schell TD, Staveley-O'Carroll KF. Sunitinib represses regulatory T cells to overcome immunotolerance in a murine model of hepatocellular cancer. Oncoimmunology. 2017; 7(1):e1372079. PMID: 29296523.
      View in: PubMed
    9. Wrangle J, Paulos CM, Smith TW, Nishimura MI, Rubinstein MP. Inducible Enhancement of T Cell Function and Anti-tumor Activity after Adoptive Transfer. Mol Ther. 2017 09 06; 25(9):1995-1996. PMID: 28830671.
      View in: PubMed
    10. Rachidi S, Metelli A, Riesenberg B, Wu BX, Nelson MH, Wallace C, Paulos CM, Rubinstein MP, Garrett-Mayer E, Hennig M, Bearden DW, Yang Y, Liu B, Li Z. Platelets subvert T cell immunity against cancer via GARP-TGFß axis. Sci Immunol. 2017 May 05; 2(11). PMID: 28763790.
      View in: PubMed
    11. Majchrzak K, Nelson MH, Bowers JS, Bailey SR, Wyatt MM, Wrangle JM, Rubinstein MP, Varela JC, Li Z, Himes RA, Chan SS, Paulos CM. ß-catenin and PI3Kd inhibition expands precursor Th17 cells with heightened stemness and antitumor activity. JCI Insight. 2017 Apr 20; 2(8). PMID: 28422756.
      View in: PubMed
    12. Mehrotra S, Britten CD, Chin S, Garrett-Mayer E, Cloud CA, Li M, Scurti G, Salem ML, Nelson MH, Thomas MB, Paulos CM, Salazar AM, Nishimura MI, Rubinstein MP, Li Z, Cole DJ. Vaccination with poly(IC:LC) and peptide-pulsed autologous dendritic cells in patients with pancreatic cancer. J Hematol Oncol. 2017 04 07; 10(1):82. PMID: 28388966.
      View in: PubMed
    13. Neitzke DJ, Bowers JS, Andrijauskaite K, O'Connell NS, Garrett-Mayer E, Wrangle J, Li Z, Paulos CM, Cole DJ, Rubinstein MP. Murine Th17 cells utilize IL-2 receptor gamma chain cytokines but are resistant to cytokine withdrawal-induced apoptosis. Cancer Immunol Immunother. 2017 Jun; 66(6):737-751. PMID: 28280853.
      View in: PubMed
    14. Liu B, Kong L, Han K, Hong H, Marcus WD, Chen X, Jeng EK, Alter S, Zhu X, Rubinstein MP, Shi S, Rhode PR, Cai W, Wong HC. A Novel Fusion of ALT-803 (Interleukin (IL)-15 Superagonist) with an Antibody Demonstrates Antigen-specific Antitumor Responses. J Biol Chem. 2016 Nov 11; 291(46):23869-23881. PMID: 27650494.
      View in: PubMed
    15. Doedens AL, Rubinstein MP, Gross ET, Best JA, Craig DH, Baker MK, Cole DJ, Bui JD, Goldrath AW. Molecular Programming of Tumor-Infiltrating CD8+ T Cells and IL15 Resistance. Cancer Immunol Res. 2016 09 02; 4(9):799-811. PMID: 27485135.
      View in: PubMed
    16. Banerjee A, Thyagarajan K, Chatterjee S, Chakraborty P, Kesarwani P, Soloshchenko M, Al-Hommrani M, Andrijauskaite K, Moxley K, Janakiraman H, Scheffel MJ, Helke K, Armenson K, Palanisamy V, Rubinstein MP, Mayer EG, Cole DJ, Paulos CM. Lack of p53 Augments Antitumor Functions in Cytolytic T Cells. Cancer Res. 2016 09 15; 76(18):5229-5240. PMID: 27466285.
      View in: PubMed
    17. Salem ML, Nassef M, Abdel Salam SG, Zidan A, Mahmoud MH, Badr G, Rubinstein M, Cole D. Effect of administration timing of postchemotherapy granulocyte colony-stimulating factor on host-immune cell recovery and CD8+ T-cell response. J Immunotoxicol. 2016 11; 13(6):784-792. PMID: 27417188.
      View in: PubMed
    18. Majchrzak K, Nelson MH, Bailey SR, Bowers JS, Yu XZ, Rubinstein MP, Himes RA, Paulos CM. Exploiting IL-17-producing CD4+ and CD8+ T cells to improve cancer immunotherapy in the clinic. Cancer Immunol Immunother. 2016 Mar; 65(3):247-59. PMID: 26825102.
      View in: PubMed
    19. Johnson CB, Wrangle J, Mehrotra S, Li Z, Paulos CM, Cole DJ, Surh CD, Rubinstein MP. Harnessing the IL-7/IL-7Ra axis to improve tumor immunotherapy. Oncoimmunology. 2016 May; 5(5):e1122865. PMID: 27467935.
      View in: PubMed
    20. Su EW, Moore CJ, Suriano S, Johnson CB, Songalia N, Patterson A, Neitzke DJ, Andrijauskaite K, Garrett-Mayer E, Mehrotra S, Paulos CM, Doedens AL, Goldrath AW, Li Z, Cole DJ, Rubinstein MP. IL-2Ra mediates temporal regulation of IL-2 signaling and enhances immunotherapy. Sci Transl Med. 2015 Oct 28; 7(311):311ra170. PMID: 26511507.
      View in: PubMed
    21. Johnson CB, Riesenberg BP, May BR, Gilreath SC, Li G, Staveley-O'Carroll KF, Garrett-Mayer E, Mehrotra S, Cole DJ, Rubinstein MP. Effector CD8+ T-cell Engraftment and Antitumor Immunity in Lymphodepleted Hosts Is IL7Ra Dependent. Cancer Immunol Res. 2015 Dec; 3(12):1364-74. PMID: 26297711.
      View in: PubMed
    22. Andrijauskaite K, Suriano S, Cloud CA, Li M, Kesarwani P, Stefanik LS, Moxley KM, Salem ML, Garrett-Mayer E, Paulos CM, Mehrotra S, Kochenderfer JN, Cole DJ, Rubinstein MP. IL-12 conditioning improves retrovirally mediated transduction efficiency of CD8+ T cells. Cancer Gene Ther. 2015 Jul; 22(7):360-7. PMID: 26182912.
      View in: PubMed
    23. Bowers JS, Nelson MH, Kundimi S, Bailey SR, Huff LW, Schwartz KM, Cole DJ, Rubinstein MP, Paulos CM. Dendritic Cells in Irradiated Mice Trigger the Functional Plasticity and Antitumor Activity of Adoptively Transferred Tc17 Cells via IL12 Signaling. Clin Cancer Res. 2015 Jun 01; 21(11):2546-57. PMID: 25904754.
      View in: PubMed
    24. Rubinstein MP, Su EW, Suriano S, Cloud CA, Andrijauskaite K, Kesarwani P, Schwartz KM, Williams KM, Johnson CB, Li M, Scurti GM, Salem ML, Paulos CM, Garrett-Mayer E, Mehrotra S, Cole DJ. Interleukin-12 enhances the function and anti-tumor activity in murine and human CD8(+) T cells. Cancer Immunol Immunother. 2015 May; 64(5):539-49. PMID: 25676709.
      View in: PubMed
    25. Nelson MH, Kundimi S, Bowers JS, Rogers CE, Huff LW, Schwartz KM, Thyagarajan K, Little EC, Mehrotra S, Cole DJ, Rubinstein MP, Paulos CM. The inducible costimulator augments Tc17 cell responses to self and tumor tissue. J Immunol. 2015 Feb 15; 194(4):1737-47. PMID: 25576595.
      View in: PubMed
    26. Li Z, Chen L, Rubinstein MP. Cancer immunotherapy: are we there yet? Exp Hematol Oncol. 2013 Dec 10; 2(1):33. PMID: 24326015.
      View in: PubMed
    27. Rubinstein MP, Salem ML, Doedens AL, Moore CJ, Chiuzan C, Rivell GL, Cole DJ, Goldrath AW. G-CSF/anti-G-CSF antibody complexes drive the potent recovery and expansion of CD11b+Gr-1+ myeloid cells without compromising CD8+ T cell immune responses. J Hematol Oncol. 2013 Oct 01; 6:75. PMID: 24279871.
      View in: PubMed
    28. Xu W, Jones M, Liu B, Zhu X, Johnson CB, Edwards AC, Kong L, Jeng EK, Han K, Marcus WD, Rubinstein MP, Rhode PR, Wong HC. Efficacy and mechanism-of-action of a novel superagonist interleukin-15: interleukin-15 receptor aSu/Fc fusion complex in syngeneic murine models of multiple myeloma. Cancer Res. 2013 May 15; 73(10):3075-86. PMID: 23644531.
      View in: PubMed
    29. Cole DJ, Rubinstein MP. Soluble IL-15/IL-15Ra complexes in human serum. Blood. 2012 Jul 05; 120(1):1-2. PMID: 22767572.
      View in: PubMed
    30. Rubinstein MP, Cloud CA, Garrett TE, Moore CJ, Schwartz KM, Johnson CB, Craig DH, Salem ML, Paulos CM, Cole DJ. Ex vivo interleukin-12-priming during CD8(+) T cell activation dramatically improves adoptive T cell transfer antitumor efficacy in a lymphodepleted host. J Am Coll Surg. 2012 Apr; 214(4):700-7; discussion 707-8. PMID: 22360982.
      View in: PubMed
    31. Elpek KG, Rubinstein MP, Bellemare-Pelletier A, Goldrath AW, Turley SJ. Mature natural killer cells with phenotypic and functional alterations accumulate upon sustained stimulation with IL-15/IL-15Ralpha complexes. Proc Natl Acad Sci U S A. 2010 Dec 14; 107(50):21647-52. PMID: 21098276.
      View in: PubMed
    32. Doedens AL, Stockmann C, Rubinstein MP, Liao D, Zhang N, DeNardo DG, Coussens LM, Karin M, Goldrath AW, Johnson RS. Macrophage expression of hypoxia-inducible factor-1 alpha suppresses T-cell function and promotes tumor progression. Cancer Res. 2010 Oct 01; 70(19):7465-75. PMID: 20841473.
      View in: PubMed
    33. D'Cruz LM, Rubinstein MP, Goldrath AW. Surviving the crash: transitioning from effector to memory CD8+ T cell. Semin Immunol. 2009 Apr; 21(2):92-8. PMID: 19269192.
      View in: PubMed
    34. Rubinstein MP, Salem ML, Kadima AN, Nguyen CL, Gillanders WE, Nishimura MI, Cole DJ. Loss of T cell-mediated antitumor immunity after construct-specific downregulation of retrovirally encoded T-cell receptor expression in vivo. Cancer Gene Ther. 2009 Feb; 16(2):171-83. PMID: 18690205.
      View in: PubMed
    35. Rubinstein MP, Lind NA, Purton JF, Filippou P, Best JA, McGhee PA, Surh CD, Goldrath AW. IL-7 and IL-15 differentially regulate CD8+ T-cell subsets during contraction of the immune response. Blood. 2008 Nov 01; 112(9):3704-12. PMID: 18689546.
      View in: PubMed
    36. Epardaud M, Elpek KG, Rubinstein MP, Yonekura AR, Bellemare-Pelletier A, Bronson R, Hamerman JA, Goldrath AW, Turley SJ. Interleukin-15/interleukin-15R alpha complexes promote destruction of established tumors by reviving tumor-resident CD8+ T cells. Cancer Res. 2008 Apr 15; 68(8):2972-83. PMID: 18413767.
      View in: PubMed
    37. Ramsey C, Rubinstein MP, Kim DM, Cho JH, Sprent J, Surh CD. The lymphopenic environment of CD132 (common gamma-chain)-deficient hosts elicits rapid homeostatic proliferation of naive T cells via IL-15. J Immunol. 2008 Apr 15; 180(8):5320-6. PMID: 18390713.
      View in: PubMed
    38. Cho JH, Boyman O, Kim HO, Hahm B, Rubinstein MP, Ramsey C, Kim DM, Surh CD, Sprent J. An intense form of homeostatic proliferation of naive CD8+ cells driven by IL-2. J Exp Med. 2007 Aug 06; 204(8):1787-801. PMID: 17664294.
      View in: PubMed
    39. Purton JF, Tan JT, Rubinstein MP, Kim DM, Sprent J, Surh CD. Antiviral CD4+ memory T cells are IL-15 dependent. J Exp Med. 2007 Apr 16; 204(4):951-61. PMID: 17420265.
      View in: PubMed
    40. Salem ML, Kadima AN, El-Naggar SA, Rubinstein MP, Chen Y, Gillanders WE, Cole DJ. Defining the ability of cyclophosphamide preconditioning to enhance the antigen-specific CD8+ T-cell response to peptide vaccination: creation of a beneficial host microenvironment involving type I IFNs and myeloid cells. J Immunother. 2007 Jan; 30(1):40-53. PMID: 17198082.
      View in: PubMed
    41. Salem ML, Gillanders WE, Kadima AN, El-Naggar S, Rubinstein MP, Demcheva M, Vournakis JN, Cole DJ. Review: novel nonviral delivery approaches for interleukin-12 protein and gene systems: curbing toxicity and enhancing adjuvant activity. J Interferon Cytokine Res. 2006 Sep; 26(9):593-608. PMID: 16978064.
      View in: PubMed
    42. McKay D, Shigeoka A, Rubinstein M, Surh C, Sprent J. Simultaneous deletion of MyD88 and Trif delays major histocompatibility and minor antigen mismatch allograft rejection. Eur J Immunol. 2006 Aug; 36(8):1994-2002. PMID: 16874736.
      View in: PubMed
    43. Rubinstein MP, Kovar M, Purton JF, Cho JH, Boyman O, Surh CD, Sprent J. Converting IL-15 to a superagonist by binding to soluble IL-15R{alpha}. Proc Natl Acad Sci U S A. 2006 Jun 13; 103(24):9166-71. PMID: 16757567.
      View in: PubMed
    44. Boyman O, Kovar M, Rubinstein MP, Surh CD, Sprent J. Selective stimulation of T cell subsets with antibody-cytokine immune complexes. Science. 2006 Mar 31; 311(5769):1924-7. PMID: 16484453.
      View in: PubMed
    45. Salem ML, Kadima AN, Zhou Y, Nguyen CL, Rubinstein MP, Demcheva M, Vournakis JN, Cole DJ, Gillanders WE. Paracrine release of IL-12 stimulates IFN-gamma production and dramatically enhances the antigen-specific T cell response after vaccination with a novel peptide-based cancer vaccine. J Immunol. 2004 May 01; 172(9):5159-67. PMID: 15100252.
      View in: PubMed
    46. Lagnado R, Rubinstein MP, Maharajan S, Dua HS. Management options for the flat corneal graft. Cont Lens Anterior Eye. 2004 Mar; 27(1):27-31. PMID: 16303524.
      View in: PubMed
    47. Rubinstein MP. Applications of contact lens devices in the management of corneal disease. Eye (Lond). 2003 Nov; 17(8):872-6. PMID: 14631391.
      View in: PubMed
    48. Nguyen CL, Salem ML, Rubinstein MP, Demcheva M, Vournakis JN, Cole DJ, Gillanders WE. Mechanisms of enhanced antigen-specific T cell response following vaccination with a novel peptide-based cancer vaccine and systemic interleukin-2 (IL-2). Vaccine. 2003 Jun 02; 21(19-20):2318-28. PMID: 12744862.
      View in: PubMed
    49. Roszkowski JJ, Yu DC, Rubinstein MP, McKee MD, Cole DJ, Nishimura MI. CD8-independent tumor cell recognition is a property of the T cell receptor and not the T cell. J Immunol. 2003 Mar 01; 170(5):2582-9. PMID: 12594285.
      View in: PubMed
    50. Rubinstein MP, Kadima AN, Salem ML, Nguyen CL, Gillanders WE, Nishimura MI, Cole DJ. Transfer of TCR genes into mature T cells is accompanied by the maintenance of parental T cell avidity. J Immunol. 2003 Feb 01; 170(3):1209-17. PMID: 12538678.
      View in: PubMed
    51. Rubinstein MP, Kadima AN, Salem ML, Nguyen CL, Gillanders WE, Cole DJ. Systemic administration of IL-15 augments the antigen-specific primary CD8+ T cell response following vaccination with peptide-pulsed dendritic cells. J Immunol. 2002 Nov 01; 169(9):4928-35. PMID: 12391205.
      View in: PubMed
    52. Lowe JB, Rubinstein MP. Distance telescopes: a survey of user success. Optom Vis Sci. 2000 May; 77(5):260-9. PMID: 10831216.
      View in: PubMed
    53. Rubinstein MP, Sud S. The use of hybrid lenses in management of the irregular cornea. Cont Lens Anterior Eye. 1999; 22(3):87-90. PMID: 16303411.
      View in: PubMed
    54. Rubinstein MP, Evans JE. Therapeutic contact lenses and eyedrops--is there a problem? Cont Lens Anterior Eye. 1997; 20(1):9-11. PMID: 16303342.
      View in: PubMed
    55. Snead MP, Rubinstein MP, Jacobs PM. The optics of fundus examination. Surv Ophthalmol. 1992 May-Jun; 36(6):439-45. PMID: 1589859.
      View in: PubMed
    56. Haire AR, Vernon SA, Rubinstein MP. Levels of visual impairment in a day centre for people with a mental handicap. J R Soc Med. 1991 Sep; 84(9):542-4. PMID: 1941857.
      View in: PubMed
    57. Snead MP, Lea SH, Rubinstein MP, Reynolds K, Haworth SM. Aniseikonia: a method of objective assessment in pseudophakia using geometric optics. Ophthalmic Physiol Opt. 1991 Apr; 11(2):109-12. PMID: 2062533.
      View in: PubMed
    58. Snead MP, Hardman Lea S, Rubinstein MP, Reynolds K, Haworth SM. Determination of the nodal point position in the pseudophakic eye. Ophthalmic Physiol Opt. 1991 Apr; 11(2):105-8. PMID: 2062532.
      View in: PubMed
    59. Hardman Lea SJ, Snead MP, Loades J, Rubinstein MP. Microtropia versus bifoveal fixation in anisometropic amblyopia. Eye (Lond). 1991; 5 ( Pt 5):576-84. PMID: 1794423.
      View in: PubMed
    60. Hardman Lea SJ, Rubinstein MP, Snead MP, Haworth SM. Pseudophakic accommodation? A study of the stability of capsular bag supported, one piece, rigid tripod, or soft flexible implants. Br J Ophthalmol. 1990 Jan; 74(1):22-5. PMID: 2306440.
      View in: PubMed
    61. Rubinstein MP, Parrish ST, Vernon SA. Corneal epithelial oxygen uptake rate in diabetes mellitus. Eye (Lond). 1990; 4 ( Pt 5):757-9. PMID: 2282951.
      View in: PubMed
    62. Snead MP, Rubinstein MP, Lea SH, Haworth SM. Calculated versus A-scan result for axial length using different types of ultrasound probe tip. Eye (Lond). 1990; 4 ( Pt 5):718-22. PMID: 2282947.
      View in: PubMed
    63. Vernon SA, Hardman-Lea S, Rubinstein MP, Snead MP. White light interferometry in amblyopic children--a pilot study. Eye (Lond). 1990; 4 ( Pt 6):802-5. PMID: 2101110.
      View in: PubMed
    64. Hardman Lea SJ, Loades J, Rubinstein MP. The interaction between hydrogel lenses and sodium fluorescein. Theoretical and practical considerations. Acta Ophthalmol (Copenh). 1989 Aug; 67(4):441-6. PMID: 2801049.
      View in: PubMed
    65. Hardman Lea SJ, Loades J, Rubinstein MP. The sensitive period for anisometropic amblyopia. Eye (Lond). 1989; 3 ( Pt 6):783-90. PMID: 2630363.
      View in: PubMed
    66. Mendoza FX, Nicholas JA, Rubinstein MP. The arthroscopic treatment of subacromial impingement. Clin Sports Med. 1987 Jul; 6(3):573-9. PMID: 3334036.
      View in: PubMed
    67. Rubinstein MP. Hospital contact lens services in the United Kingdom. Health Trends. 1984 Aug; 16(3):53-6. PMID: 10268945.
      View in: PubMed
    68. Harding GF, Rubinstein MP. The visually evoked subcortical potential to flash stimulation in normal subjects and patients with lesions of the visual pathway. Adv Neurol. 1982; 32:31-9. PMID: 7054954.
      View in: PubMed
    69. Rubinstein MP, Harding GF. The visually evoked subcortical potential: is related to the electroretinogram? Invest Ophthalmol Vis Sci. 1981 Aug; 21(2):335-44. PMID: 7251311.
      View in: PubMed
    70. Harding GF, Rubinstein MP. The scalp topography of the human visually evoked subcortical potential. Invest Ophthalmol Vis Sci. 1980 Mar; 19(3):318-21. PMID: 7358484.
      View in: PubMed
    Rubinstein's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description
    Physical Neighbors Expand Description
    _